Mediclass Austria

Interview with Martin Spatz, General Manager, Teva Ratiopharm Austria

Dr Spatz, what would you highlight as the main specificities of the Austrian generic market, and explain how Teva has adapted its approach to the Austrian environment? Teva recently changed…

Interview with Karl Nikitsch, Menarini Austria

Dr. Nikitsch, you started Menarini’s Austrian operations almost 13 years ago. Would you say that Menarini’s presence in Austria today reflects the vision you had for the company in Austria…

Interview with Martin Peithner, MBA, General Manager, Austroplant Arzneimittel

Can you give our readers a snapshot of Austroplant’s scope of activities and its structure in Austria and the central European market? Austroplant/Dr Peithner belongs to the Schwabe Group, the…

Interview with Bernd Leiter, President, Austria’s Generics Industry…

Just like other European countries, Austria is in the search for meaningful savings in healthcare. Austria’s increasingly price sensitive pharma market is seeing the rise of generic medicines gaining market…

Interview with Berthold Cvach, Managing Director, Astellas Austria

Whereas most General Managers are exposed to different countries during their professional career, you have chosen to dedicate yours to the Austrian market. What is it in this country so…

Interview with Jan Oliver Huber, General Secretary, Austrian Pharmaceutical…

You have been General Secretary of PHARMIG since 2004 and have witnessed the market’s development over the past 8 years. What have been the most important changes since you started…